KPF
LBPSW

K2 Principal Fund’s 4D Pharma PLC Warrant LBPSW Stock Holding History

K2 Principal Fund’s Portfolio LBPSW Stock Details LBPSW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-550,944
Closed -$601K – 477
2021
Q1 		$601K Buy
+550,944
New +$689K 0.05% 238

Other funds holding LBPSW

BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return

K2 Principal Fund's LBPSW Position: Q2 2021 in Review

K2 Principal Fund sold out of 4D Pharma PLC Warrant (LBPSW) in Q2 2021, closing a stake of 550,944 shares — an estimated $601K sold.

K2 Principal Fund first reported a position in LBPSW in Q1 2021 and held it in 1 quarter. The position peaked at $601K in Q1 2021. 5 funds tracked by Wall St. Rank hold LBPSW as of Q2 2021.

  • K2 Principal Fund reported no remaining 4D Pharma PLC Warrant position as of Q2 2021 after selling out during the quarter.
  • K2 Principal Fund sold 550,944 4D Pharma PLC Warrant shares in Q2 2021, an estimated $601K.
  • K2 Principal Fund first reported a position in 4D Pharma PLC Warrant in Q1 2021 and held it in 1 quarter.
  • K2 Principal Fund's 4D Pharma PLC Warrant position peaked at $601K in Q1 2021.
  • 5 funds tracked by Wall St. Rank held 4D Pharma PLC Warrant as of Q2 2021.

Based on K2 Principal Fund's 13F filing for Q2 2021, filed 13 Aug 2021.